WestEnd Advisors’s DexCom DXCM Stock Holding History

WestEnd Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$808	Buy	12 +2	+20%	+$133	﹤0.01%	302
2026 Q1	$628	Hold	10	–	–	﹤0.01%	293
2025 Q4	$664	Sell	10 -2	-17%	-$129	﹤0.01%	285
2025 Q3	$807	Sell	12 -4	-25%	-$317	﹤0.01%	262
2025 Q2	$1.4K	Buy	16 +1	+7%	+$78	﹤0.01%	187
2025 Q1	$1.02K	Buy	15 +10	+200%	+$816	﹤0.01%	209
2024 Q4	$389	Hold	5	–	–	﹤0.01%	202
2024 Q3	$335	Hold	5	–	–	﹤0.01%	231
2024 Q2	$567	Sell	5 -1	-17%	-$126	﹤0.01%	153
2024 Q1	$832	Hold	6	–	–	﹤0.01%	122
2023 Q4	$745	Buy	6 +1	+20%	+$102	﹤0.01%	127
2023 Q3	$467	Buy	+5	New	+$564	﹤0.01%	159
2023 Q1	–	Sell	-5	Closed	-$560	–	143
2022 Q4	$566	Hold	5	–	–	﹤0.01%	139
2022 Q3	$0	Hold	5	–	–	﹤0.01%	190
2022 Q2	$372	Buy	+5	New	+$456	﹤0.01%	153
2022 Q1	–	Sell	-4	Closed	-$438	–	149
2021 Q4	$536	Buy	+4	New	+$575	﹤0.01%	151
2021 Q3	–	Hold	0	–	–	–	140
2021 Q2	–	Hold	0	–	–	–	162

Other funds holding DXCM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

FFM

Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

FMI

Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

WestEnd Advisors's DXCM Position: Q2 2026 in Review

WestEnd Advisors increased its DexCom (DXCM) stake by 20% in Q2 2026, buying an estimated $133 and bringing the position to 12 shares worth $808. The position accounts for ﹤0.01% of the portfolio, ranked #302.

WestEnd Advisors first reported a position in DXCM in Q4 2021 and has held it in 16 quarters since. The position peaked at $1.4K in Q2 2025. 224 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

WestEnd Advisors held 12 shares of DexCom worth $808 as of Q2 2026.
WestEnd Advisors bought 2 DexCom shares in Q2 2026, an estimated $133.
DexCom made up ﹤0.01% of WestEnd Advisors's portfolio in Q2 2026, its #302 holding.
WestEnd Advisors first reported a position in DexCom in Q4 2021 and has held it in 16 quarters since.
WestEnd Advisors's DexCom position peaked at $1.4K in Q2 2025.
224 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on WestEnd Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.